-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III

Symposia: Myeloproliferative Syndromes: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Claire N. Harrison, DM1, Marina Kremyanskaya, MD, PhD2, Prithviraj Bose, MD3, Vikas Gupta, MD, FRCP, FRCPath4, Raajit K Rampal, MD, PhD5, Jonathan Lambert, BmedSci, PhD, FRCP, FRCPath6*, Moshe Talpaz, MD7, Alessandro Vannucchi, MD8, Andrew Kuykendall, MD9, Jean-Jacques Kiladjian, MD10, Srdan Verstovsek, MD, PhD11, Ruben Mesa, MD, FACP12, Gozde Colak, PhD13*, Sandra Klein, PhD13*, Soumik Dutta, PhD14* and John Mascarenhas, MD15

1Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
3The University of Texas MD Anderson Cancer Center, Houston, TX
4Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
5Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
6University College London Hospitals NHS Foundation Trust, London, United Kingdom
7University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
8University of Florence, Azienda Ospedaliero Universitaria Careggi, CRIMM, Florence, Italy
9Department of Malignant Hematology, H. Lee Mofitt Cancer Center, Tampa, FL
10Hopital Saint-Louis, Paris, France
11Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, TX
12Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
13Constellation Pharmaceuticals, Inc., a MorphoSys Company, Boston, MA
14MorphoSys AG, Planegg, Germany
15Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

Jean-Jacques Kiladjian, MD1, Christoph Klade, PhD2*, Pencho Georgiev, MD3*, Dorota Krochmalczyk, MD4*, Liana Gercheva-Kyuchukova, MD5*, Miklos Egyed, MD, PhD6*, Petr Dulicek, MD7*, Arpad Illes, MD8*, Halyna Pylypenko, MD9*, Lylia Sivcheva, MD10*, Jiří Mayer, MD11, Vera Yablokova, MD12*, Kurt Krejcy, MD2*, Victoria Empson, MSc13*, Hans Carl Hasselbalch, MD14, Robert Kralovics, PhD15 and Heinz Gisslinger, MD16*

1Centre d'Investigations Cliniques (INSERM CIC 1427), AP-HP, Hôpital Saint-Louis, Université Paris Cité, Paris, France
2AOP Orphan Pharmaceuticals GmbH, Vienna, Austria
3Medical University of Plovdiv, Plovdiv, Bulgaria
4Teaching Unit of the Hematology Department, University Hospital in Krakow, Kracow, Poland
5Clinical Hematology Clinic, Multiprofile Hospital for Active Treatment "Sveta Marina", Varna, Bulgaria
6Department of Internal Medicine II, Kaposi Mor County Teaching Hospital, Kaposvar, Hungary
7Department of Clinical Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
8Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
9Regional Treatment and Diagnostics Haematology Centre, Cherkassy Regional Council, Cherkassy, Ukraine
10First Department of Internal Medicine, Multiprofile Hospital for Active Treatment - HristoBotev, Vratsa, Bulgaria
11Clinic of Internal Medicine-Haematology and Oncology, University Hospital Brno, Brno, Czech Republic
12Department of Hematology, Yaroslavl Regional Clinical Hospital, Yaroslavl, Russian Federation
13AOP Orphan Pharmaceuticals GmbH, Vienna, Vienna, Austria
14Department of Hematology, Zealand University Hospital, Roskilde, Denmark
15Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
16Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University Vienna, Vienna, Austria

Rosa Ayala1*, Nieves Lopez1*, Adi Shacham Abulafia, MD2*, Maan Alwan3*, Costas K. Yannakou, MBBS4*, Indu Raman4*, Vincent Ribrag, MD5, Chun Yew Fong, MBBS, PhD, FRACP, FRCPA6, Yulia Volchek7*, Massimiliano Bonifacio, MD8*, Alessandra Tucci, MD9*, Jean-Jacques Kiladjian, MD10, Henry Chang11*, Sharmila Das12*, Bin Wu13*, Palanikumar Ravindran14*, Vivian Shan12*, Guan Wang14*, Oriana Esposito15*, Yu Liu13*, Zariana Nikolova15*, Christopher Tehlirian13*, Shodeinde Coker14* and David Lavie, MD16*

1Hematology and Hemotherapy Department, Hospital Universitario 12 de Octubre, CNIO, Complutense University, CIBERONC, Madrid, Spain
2Institute of Hematology, Davidoff Cancer Centre, Beilinson Hospital, Rabin Medical Centre, Petah-Tiqva, Israel
3Perth Blood Institute, West Perth, Western Australia, Australia
4Epworth HealthCare, Melbourne, VIC, Australia
5Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer, Villejuif, France
6Department of Haematology, Austin Hospital, Heidelberg, VIC, Australia
7Department of Hematology, Assaf Harofeh Medical Center, Zeriffin, Israel
8Department of Medicine, Section of Hematology, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy
9Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
10Centre d'Investigations Cliniques (CIC 1427), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, INSERM, Université Paris 7, Paris, France
11Bristol Myers Squibb, San Francisco, CA
12Bristol Myers Squibb, Princeton, NJ
13Bristol Myers Squibb, Cambridge, MA
14Bristol Myers Squibb, Lawrenceville, NJ
15Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain
16Hadassah Medical Center, Jerusalem, Israel

Yannick LE Bris, PhD, PharmD1,2*, Jean Galtier3*, Dina Naguib, MD4*, Mathieu Wemeau, MD5,6*, Jean Claude Chomel, MD7*, Laurence Legros, MD, PhD8*, Yan Beauverd, MD9*, Lise Willems, MD10*, Guillaume Denis, MD11*, Françoise Boyer perrard12*, Damien Luque-Paz, PharmD, PhD13*, Kamel Laribi, MD14*, Mélanie Mercier, MD15*, Pascale Cony-Makhoul, MD16*, Olivier Herault, MD17, Lydia Roy, MD18*, Pierre Sujobert, MD, PhD19*, Lenaig Le Clech, MD20*, Sylvie Tondeur, PharmD PhD21*, Gaelle Laboure, MD22*, Jerome Rey, MD23*, Guillou Sophie, MD24*, Cedric Pastoret, MD, PhD25*, Pascaline Etancelin, MD26*, Suzanne Tavitian, MD27*, Charles Bescond, MD28*, Francois Girodon, MD, PhD 29, Shanti Amé, MD30*, Viviane Dubruille, MD31*, Eric Lippert, MD, PhD32*, Chloe James, MD, PhD33*, Barbara Burroni, MD34*, Marc Fouassier, MD35*, Marie C Béné, PharmSciD, PhD36* and Jean Christophe Ianotto, MD, PhD37*

1Hematology Biology, CHU Nantes, Nantes, France
2CRCINA, INSERM, CNRS, Angers University and Nantes University, Nantes, France
3CHU Bordeaux, Service d'hématologie clinique et thérapie cellulaire, PESSAC, FRA
4Laboratoire d'hématologie, CHU de Caen Normandie, Caen, Ca, France
5Hématologie Clinique, Centre Hospitalier de Roubaix, Roubaix, France
6CHRU Lille, Paris, FRA
7CHU De Poitiers, Poitiers, FRA
8Hematology department, Hôpital Paul Brousse, Villejuif, France
9Geneva University Hospitals, Geneva, Switzerland
10Department of Hematology, APHP, Hôpital Cochin, Paris, France
11Department of Internal Medicine and Hematology, Rochefort Hospital, Rochefort, France
12Service des maladies du sang, Centre Hospitalier Universitaire d’Angers, Angers, France
13Hematology biology, CHU Angers, Angers, France
14Hématologie clinique, CH Le Mans, Le Mans, France
15Clinical Hematology, Centre Hospitalier Bretagne Atlantique, Vannes, France
16Service d'Hématologie, Centre Hospitalier Annecy-Genevois, Pringy, France
17Service d'Hématologie Biologique, Centre Hospitalier Universitaire, Tours, France
18Hematology department, Hopital Henri Mondor, Creteil, France
19Laboratory of Hematology, Centre Hospitalier Lyon Sud, Pierre Bénite, France
20Hematology clinic, Centre Hospitalier de Quimper, Quimper, France
21Laboratoire de Génétique des hémopathies, CHU Grenoble Alpes, Grenoble, France
22Centre Hospitalier de Libourne, Libourne, France
23Onco-Hematology Department, Paoli-Calmette Cancer Institute, Marseille, France
24Hematology biology, CHU Reims, Reims, France
25INSERM U1236 /Hematology Laboratory, University Hospital of Rennes, RENNES, FRA
26Centre Henri Becquerel, Rouen, FRA
27Service d'Hématologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
28CHU De Nantes, Nantes, FRA
29Laboratorie D'Hematologie CHU Dijon, Dijon, France
30Hematology department, Hopital Civil , CHU Strasbourg, Strasbourg, France
31Hematology Department, Nantes University Hospital, Nantes, France
32France Intergroupe des Néoplasies Myéloprolifratives, FIM collaborative group, Paris, France
33UMR Inserm U1034, 33600, FRA
34Pathology Department, Hopital Cochin, Paris, France
35CHRU Hotel Dieu, Nantes cedex, FRA
36Biology Department, Nantes University Hospital, Nantes, France
37Department of Hematology, CHU de Brest, Brest, FRA

Srdan Verstovsek, MD, PhD1, Ruben Mesa, MD, FACP2, Vikas Gupta, MD, FRCP, FRCPath3, David Lavie, MD4*, Viviane Dubruille, MD5*, Nathalie Cambier, MD6*, Uwe Platzbecker, MD7, Marek Hus, MD, PhD8*, Blanca Xicoy, MD9*, Stephen T Oh, MD, PhD10, Jean-Jacques Kiladjian, MD11, Alessandro M Vannucchi, MD12, Aaron T. Gerds, MD, MS13, Miklos Egyed, MD, PhD14*, Jiri Mayer, Prof, MD15*, Tomasz Sacha, MD, PhD16*, Jun Kawashima, MD17*, Marc Morris17*, Mei Huang, MS17* and Claire N. Harrison, DM18

1Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, TX
2UT Health San Antonio Cancer Center, San Antonio, TX
3Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
4Hadassah-Hebrew University Medical Centre, Jerusalem, Israel
5Hematology Department, Nantes University Hospital, Nantes, France
6Hospital Saint Vincent de Paul—GHICL Lille, Lillie, France
7Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
8Medical University of Lublin, Lublin, Poland
9Universitat Autònoma de Barcelona, Barcelona, Spain
10Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
11Université de Paris, AP-HP, Hôpital Saint-Louis, Centre d’Investigations Cliniques, Paris, France
12University of Florence, Firenze, Italy
13Department of Hematology and Medical Oncology,, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
14Somogy County Mór Kaposi General Hospital, Kaposvár, Hungary
15Masaryk University and University Hospital Brno, Brno, Czech Republic
16Jagiellonian University Hospital, Kraków, Poland
17Sierra Oncology Inc., San Mateo, CA
18Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom

Andreas K. Oevlisen, MD1*, Daniel Kristensen, MD1*, Lasse Hjort Jakobsen, MSc, PhD1,2*, Marianne Tang Severinsen, MD, PhD1,3*, Tarec Christoffer Christoffer El-Galaly, MD, DSc1,3 and Anne Stidsholt Roug, MD, PhD1,3,4*

1Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
2Department of Mathematical Science, Aalborg University, Aalborg, Denmark
3Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
4Department of Hematology, Aarhus University Hospital, Aarhus, Denmark

Naseema Gangat, MBBS1, Rimal Ilyas, MBBS2*, Kristen McCullough, PharmD3, Kebede H. Begna, MD4, Aref Al-Kali, MD1, Mrinal M. M. Patnaik, MD, MBBS1, Mark R. Litzow, MD1, William J. Hogan, MB, BCh1, Abhishek A. Mangaonkar, MBBS1, Hassan B. Alkhateeb, MD1*, Mithun V. Shah, MD, PhD1, Michelle A Elliott, MD1, James M. Foran, MD5, Talha Badar, MD6, Jeanne M. Palmer, MD7, Curtis A. Hanson, MD8, Animesh Pardanani, MBBS, PhD 1 and Ayalew Tefferi, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, Rochester, MN
3Division of Pharmacology, Mayo Clinic, Rochester, MN
4Divison of Hematology, Mayo Clinic, Rochester, MN
5Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
6Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL
7Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
8Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Ruben Mesa, MD, FACP1,2, Claire N. Harrison, DM3, Jeanne M. Palmer, MD4, Vikas Gupta, MD, FRCP, FRCPath5, Donal P. McLornan, MD, PhD6*, Mary Frances McMullin, MD, FRCPath, FRCP7, Jean-Jacques Kiladjian, MD8, Lynda Foltz, MD, FRCPC9, Uwe Platzbecker, MD10, Maria Laura Fox, MD11*, Adam J Mead, MD PhD12, David M Ross, MBBS, PhD, FRACP, FRCPA13*, Stephen T Oh, MD, PhD14, Andrew Charles Perkins, MBBS, PhD15, Michael F. Leahy, FRACP, FRCPath, FRCP16, Jun Kawashima, MD17*, Sunhee Ro, PhD17*, Rafe Donahue, PhD17*, Samineh Deheshi, PhD18* and Srdan Verstovsek, MD, PhD19

1UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
2UT Health San Antonio Cancer Center, San Antonio, TX
3Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom
4Mayo Clinic, Phoenix, AZ
5Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
6Haematology Department, Guy's and St Thomas' NHS Trust, London, United Kingdom
7Centre for Medical Education, Queen's University, Belfast, United Kingdom
8Clinical Investigations Center, Saint-Louis hospital, Université de Paris, Paris, France
9University of British Columbia, Vancouver, BC, Canada
10University Hospital Leipzig, Leipzig, Germany
11University Hospital Vall d’Hebron, Barcelona, Spain
12Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
13Royal Adelaide Hospital and SA Pathology, Adelaide, Australia
14Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
15Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia
16PathWest Laboratory Medicine WA, Perth, Australia
17Sierra Oncology Inc., San Mateo, CA
18Sierra Oncology Inc., Vancouver, BC, Canada
19MD Anderson Cancer Center, University of Texas, Houston, TX

Jessie J. F. Medeiros, BSc1,2, Andy G.X. Zeng, BSc1,2, Michelle Chan-Seng-Yue3*, Tristan Woo1*, Jessica L McLeod4*, Andrea Arruda, MSc5*, Hubert Tsui, MD, PhD, FRCPC6,7,8,9, Burhan Goraya1*, Jaime O. Claudio, PhD1,10*, Jenny M. Ho, MD11,12, James A. Kennedy, MD, PhD13,14, Dawn Maze, MD, FRCPC, MSc15, Hassan Sibai, MBBS, MD16*, Mark D. Minden, MD, PhD17, Jean C.Y. Wang, MD1,17,18, John E. Dick, PhD1,2 and Vikas Gupta, MD, FRCP, FRCPath1

1Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
3Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, ON, Canada
4Phillip Orsino Cell Processing Laboratory, Princess Margaret Cancer Centre, Toronto, ON, Canada
5University Health Network, Toronto, ON, Canada
6Division of Hematological Pathology, Precision Diagnostics and Therapeutics Program, University of Toronto, Toronto, ON, Canada
7Sunnybrook Research Institute, Toronto, Canada
8Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
9Department of Immunology, University of Toronto, Toronto, Canada
10Division of Medical Oncology and Hematology, University of Toronto, Toronto, Canada
11Division of Hematology, London Health Sciences Centre, London, ON, Canada
12Department of Medicine, University of Western Ontario, London, ON, Canada
13Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
14Sunnybrook Health Sciences Centre, Toronto, ON, Canada
15Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
16Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada
17Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
18Department of Medicine, University of Toronto, Toronto, Canada

Lucia Masarova, MD1, Prithviraj Bose, MD2, Naveen Pemmaraju, MD1, Mary Ann Richie1*, Gautam Borthakur, MD1, Zeev E. Estrov, MD1, Hagop Kantarjian, MD3, Keyur P. Patel, MBBS, PhD4 and Srdan Verstovsek, MD, PhD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Cristina Papayannidis, MD, PhD1, Francesco Mannelli, MD2*, Lara Crosera, MD3*, Roberta Parente, MD4*, Alessandra Romano, MD, PhD5, Michela Rondoni, MD6*, Chiara Elena, MD7*, Marianna Criscuolo, MD8*, Nicola Di Renzo, MD9*, Fiorina Giona, M.D.10, Fabrizio Pane, MD11, Daniela Cilloni, MD12*, Elena Maria Elli, MD13*, Maurizio Miglino, MD, PhD14*, Patrizio Mazza, MD15*, Alessandra Malato, MD16*, Lara Pochintesta, MD17*, Roberta Bini, MSc18*, Diletta Valsecchi, MSc18* and Federica Irene Grifoni, MD19*

1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy, Bologna, Italy
2SOD Ematologia, CRIMM (Center Research and Innovation of Myeloproliferative Neoplasms), Azienda Ospedaliera Universitaria Careggi, Firenze, Italy
3Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy
4"Scuola Medica Salernitana", Università di Salerno, Salerno, Italy
5Università degli Studi di Catania, Catania, Italy
6Hematology Unit, Azienda USL della Romagna, Ravenna, Italy
7Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
8Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
9UOC Ematologia e Trapianto di Cellule Staminali, PO Vito Fazzi, Lecce, Italy
10Department of Translational and Precision Medicine - Sapienza University of Rome, AOU Policlinico Umberto I, Rome, Italy
11Division of Hematology and Bone Marrow Transplantation, Department of Medicine and Surgery University of Naples Federico II, Napoli, Italy
12Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano, Italy
13San Gerardo Hospital, ASST Monza, Monza, Italy
14Ospedale San Martino, Genova, Italy
15Ospedale San Giuseppe Moscati, Statte, Italy
16Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
17Division of Hematology, "G.da Saliceto" Hospital, Piacenza, Italy
18Novartis Farma SpA, Origgio, Italy
19Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Hematology Unit, Milan, Italy

Massimo Breccia, MD1*, Paola Guglielmelli, MD, PhD2, Francesco Mendicino3*, Alessandra Malato, MD4*, Giuseppe A. Palumbo5*, Carmine Selleri6, Daniela Cilloni, MD7*, Patrizio Mazza, MD8*, Sergio Siragusa, MD9, Elisabetta Abruzzese, MD10, Maurizio Martelli11*, Giulia Benevolo, MD12*, Erminia Rinaldi13*, Monica Crugnola, MD14*, Serena Rupoli, MD15*, Vincenzo Pavone16*, Massimiliano Bonifacio, MD17*, Fabrizio Pane, MD18, Giuseppe Carli19*, Maria Langella20*, Marta Bruno Ventre21*, Elena Maria Elli, MD22*, Stefana Impera, MD23*, Anna Marina Liberati24, Nicola Di Renzo, MD25*, Bruno Martino26*, Paolo Sportoletti, MD27*, Mario Tiribelli, MD28*, Gianni Binotto, MD29*, Mario Annunziata30*, Mauro Di Ianni31*, Giorgio La Nasa32*, Antonietta Pia Falcone33*, Rossana Leanza34*, Antonio Volpe35*, Filippo Gherlinzoni36*, Valerio De Stefano, MD37*, Daniele Vallisa38, Sabrina Leonetti Crescenzi, MD39*, Francesco Cavazzini, MD40*, Alessandra Ricco, MD41*, Carmela Barberio42*, Alessandra Misto42*, Francesco Passamonti, MD43* and Francesca Palandri, PhD, MD44*

1Division of Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
2CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
3U.O.C. di Ematologia, Azienda Ospedaliera "Annunziata", Cosenza, Italy
4UOC di Oncoematologia Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
5Dipartimento di Scienze Mediche Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", Unità Operativa di Ematologia con TMO AOU "Policlinico - San Marco", Università degli Studi di Catania, Catania, Italy
6UOC di Ematologia e Trapianti di Cellule Staminali Emopoietiche, Dipartimento di Medicina, Università di Salerno, AOU San Giovanni di Dio e Ruggi D'Aragona, Salerno, Italy
7Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
8Dept. of Hematology-Oncology, Ospedale Moscati, Taranto, Italy
9UOC di Ematologia, Azienda Ospedaliero-Universitaria Policlinico “P. Giaccone”, Palermo, Italy
10Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy
11Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
12Ematologia U, A.O.U. Città della Salute e della Scienza, Turin, Italy
13Hematology, A. Perrino Hospital, Brindisi, Italy
14Hematology and BMT Center, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
15Clinic of Hematology, Ospedali Riuniti di Ancona, Ancona, Italy
16Department of Haematology and Bone Marrow Transplantation, “Card. G. Panico” Hospital, Tricase, Italy, Tricase, Italy
17Department of Medicine, Section of Hematology, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy
18Division of Hematology and Bone Marrow Transplantation, Department of Medicine and Surgery University of Naples Federico II, Napoli, Italy
19U.O.C. Ematologia Ospedale san Bortolo, Vicenza, Italy
20U.O. Oncoematologia, Presidio Ospedaliero Andrea Tortora - ASL Salerno, Salerno, Italy
21Divisione di Oncologia, ASST Fatebenefratelli Sacco, Milano, Italy
22Divisione di Ematologia adulti e Unità trapianto di midollo ASST Monza Azienda Ospedaliera San Gerardo, Monza, Italy
23UOC Ematologia, Dipartimento Oncologico- ARNAS Garibaldi, Catania, Italy
24Oncoematologia , AO S Maria di Terni - Università degli Studi di Perugia, Perugia, Italy
25U.O. Ematologia, Presidio Ospedaliero Vito Fazzi ASL, Lecce, Italy
26Hematology Unit, Department of Hemato-Oncology and Radiotherapy,Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy
27Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy
28Clinica Ematologica, Az.Osped.-Universit.Santa Maria della Misericordia di Udine, Udine, Italy
29Hematology and Clinical Immunology Unit, Department of Medicine, Padua University Hospital, Padova, Italy
30Divisione di Ematologia, Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli, Napoli, Italy
31Department of Medicine and Aging Sciences, University of Chieti-Pescara, Pescara, Italy
32S.C Ematologia e CTMO, A O Brotzu Osp Onc Armando Businco Centro Rif Onc Reg, Cagliari, Italy
33Unità di Ematologia, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
34U.O.C. Ematologia, Az.Ospe.Universitaria Policlinico G. Martino Univ di Messina, Messina, Italy
35Ematologia, Az Ospedaliera SG Moscati, Avellino, Italy
36Unità Operativa Complessa di Ematologia, Pres.Ospedaliero S.Maria di Ca' Foncello, Treviso, Italy
37Sezione di Ematologia, Università Cattolica, Fondazione Policlinico A. Gemelli IRCCS, Roma, Italy
38Ematologia e Centro Trapianti, Dipartimento di Oncologia-Ematologia, Presidio U.Ospedaliero di Piacenza AUSL Piacenza, Piacenza, Italy
39S.C. Ematologia, Azienda Ospedaliera S Giovanni Addolorata, Roma, Italy
40Ematologia, Az Osp Univ Ferrara Arcispedale S Anna Univ. degli Studi Ferrara, Ferrara, Italy
41UOC Ematologia, Az. Osp. Univ Policlinico, Bari, Bari, Italy
42Novartis Farma S.p.A., Origgio, Italy
43Università degli Studi dell'Insubria, Ospedale di Circolo - ASST Sette Laghi, Varese, Italy
44IRCCS Azienda Ospedaliero-Universitaria S. Orsola-Malpighi, Bologna, Istituto di Ematologia "Seràgnoli, Bologna, Italy

Roberto Latagliata, MD1*, Alessandro Andriani2*, Massimo Breccia, MD3*, Ida Carmosino, MD4*, Federico Vozella, MD5*, Atelda Romano, MD6*, Annalisa Biagi, MD7*, Luca Maurillo, MD8*, Malgorzata Monika Trawinska, MD9*, Katia Paciaroni, MD10*, Michelina Santopietro, MD11*, Sabrina Leonetti Crescenzi, MD12*, Ada D'Addosio, MD13*, Caterina Tatarelli, MD, PhD14*, Elisabetta Abruzzese, MD15, Ambra Di Veroli, MD1*, Elena Rossi, MD, PhD16*, Valerio De Stefano, MD16* and Marco Montanaro, MD17*

1Hematology, Belcolle Hospital, Viterbo, Italy
2Latial Group for the Study of Myeloproliferative Neoplasms, Rome, Italy
3Division of Hematology, Department of Translational and Precision Medicine, Azienda Policlinico Umberto I, Sapienza University, Rome, Italy
4Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
5Hematology and Stem cell transplantation, Campus Biomedico University, Rome, Italy
6Hematology, Istituto Nazionale Tumori Regina Elena - IFO, Rome, Italy
7Hematology, Santa Maria Goretti Hospital – Polo Pontino “Sapienza” University, Latina, Italy
8Department of Onco-Hematology, Policlinico Tor Vergata, Rome, Rome, Italy
9Hematology S. Eugenio Hospital, ASL RM2, Rome, Italy
10UOSD Hematology, ASL RM1, Rome, Italy
11U.O. di Ematologia e Trapianti di cellule Staminali. A.O.S. S. Camillo-Forlanini, Rome, Italy
12S.C. Ematologia, Azienda Ospedaliera S Giovanni Addolorata, Roma, Italy
13Hematology, Villa San Pietro Hospital, Rome, Italy
14Hematology, Sant'Andrea Hospital - University Sapienza of Rome, Roma, ITA
15Department of Hematology S. Eugenio Hospital, Rome, Italy
16Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A Gemelli, IRCCS, Rome, Italy
17Hematology, Belcolle Hospital, Viterbo, ITA

Chen Zhang, MD1, Douglas Tremblay, MD2, John Magnotti, PhD1,3*, Lukas Ronner, MD MSCR4, Nikolai A. Podoltsev, MD, PhD5, Jason Gotlib, MD, MS6, Mark L. Heaney, MD7, Andrew Kuykendall, MD8, Casey L. O'Connell, MD9, Angela G Fleischman, MD, PhD10, Ruben Mesa, MD, FACP11, Abdulraheem Yacoub, MD12, John Mascarenhas, MD13 and Jamile M. Shammo, MD14

1Rush University Graduate College, Chicago, IL
2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
3Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA
4Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
5Yale School of Medicine, New Haven, CT
6Stanford Cancer Center, Stanford, CA
7Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
8Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
9Jane Anne Nohl Division of Hematology, Keck School of Medicine of the University of Southern California, Los Angeles, CA
10University of California, Irvine, Irvine, CA
11Mays Cancer Institute, UT Health San Antonio MD Anderson, San Antonio, TX
12The University of Kansas Cancer Center, Leawood, KS
13Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
14Division of Hematology/Oncology, Rush University Medical Center, Chicago, IL

Justin Watts, MD1*, Anthony M. Hunter, MD2*, Alessandra Iurlo, MD, PhD3*, Blanca Xicoy, MD4*, Francesca Palandri, PhD, MD5*, Brandi Reeves, MD6, Alessandro M. Vannucchi, MD7*, Xuejun Chen, PhD8*, Francis Seguy, MSc9*, Feng Zhou, PhD8*, Fred Zheng, MD8* and Pankit Vachhani, MD10*

1Sylvester Cancer Center, University of Miami, Miami, FL
2Emory University School of Medicine, Atlanta, GA
3Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
4HU German Trias i Pujol - Institut Català d' Oncologia, Barcelona, Spain
5IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy
6University of North Carolina School of Medicine, Chapel Hill, NC
7AOU Careggi, University of Florence, Florence, Italy
8Incyte Corporation, Wilmington, DE
9Incyte Biosciences International Sàrl, Morges, Switzerland
10O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL

Andreas Schmidt, MD1*, Christiane Bernhardt, MD2*, Anette Fries, MD3*, Kathleen Jentsch-Ulrich, MD4*, Andreas Josting5*, Stephan Kreher, MD6*, Marcel Reiser7*, H. Tilman Steinmetz, MD8*, Hans Tesch, MD9*, Bernhard Kaufmann, PhD10*, Uta Rager, MPH11*, Carl C. Crodel, MD12*, Francesca Palandri, PhD, MD13* and Florian H. Heidel, MD14

1Internal Medicine C, University Medicine Greifswald, Greifswald, Germany
2Gemeinschaftspraxis Hämatologie udn Onkologie Dortmund, Dortmund, Germany
3Onkologische Schwerpunktpraxis Bamberg, Bamberg, Germany
4Gemeinschaftspraxis Hämatologie und Onkologie Magdeburg, Magdeburg, Germany
5Praxis OnkoBer internistische Facharztpraxis, Berlin, Germany
6Hämatologisch-Onkologische Schwerpunktpraxis Bad Liebenwerda, Bad Liebenwerda, Germany
7PIOH Center, Cologne, Germany
8MV-Center for Hematology and Oncology, Cologne, Germany
9Onkologie Bethanien Frankfurt, Frankfurt a.M., Germany
10Novartis Pharma GmbH, Nuernberg, DEU
11Novartis Pharma GmbH, Nürnberg, Germany
12Abteilung Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Germany
13IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy
14Innere Medicin C, Universitätsmedizin Greifswald, Greifswald, Germany

Audrey Desilets, MD1,2*, Michael Harnois3*, Lambert Busque, MD2,3,4 and Natasha Szuber, MD, MSc2,3,4

1Department of Medicine, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
2University of Montreal, Montreal, QC, Canada
3Groupe Québécois de Recherche en LMC-NMP/Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Quebec Research Group (GQR LMC-NMP), Montreal, QC, Canada
4Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada

Claire N. Harrison, DM1, Shuh Ying Tan, MBBS2*, David M Ross, MBBS, PhD, FRACP, FRCPA3*, George Kannourakis, MB.BS, B(Med)Sci, PhD, FRACP4, Allie McGinty5*, Wei Feng, PhD5*, Ying Jiang, PhD5*, Christine Graham, PhD6*, Chris Rovaldi, MSc5*, Simon Cooper, MBBS5* and Jen L. Salstrom, MD, PhD5

1Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom
2St Vincent’s Hospital Melbourne, Fitzroy, VIC, Australia
3Department of Haematology, Flinders Medical Centre and University, Adelaide, SA, Australia
4Fiona Elsey Cancer Research Institute and Federation University Australia, Ballarat, Australia
5Keros Therapeutics, Lexington, MA
6Keros Therapeutics, Haverhill, MA

Rimal Ilyas, MBBS1*, Kristen McCullough, PharmD2, Talha Badar, MD3, Mrinal M. M. Patnaik, MD, MBBS4, Hassan B. Alkhateeb, MD4*, Abhishek A. Mangaonkar, MBBS4, Animesh Pardanani, MBBS, PhD 4, Ayalew Tefferi, MD4 and Naseema Gangat, MBBS4

1Mayo Clinic, Rochester, MN
2Division of Pharmacology, Mayo Clinic, Rochester, MN
3Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL
4Division of Hematology, Mayo Clinic, Rochester, MN

Oni Chowdhury1, Sophie Reed, BSc1*, Alison Telford, PhD2*, Adriana Roca-Fernandez, BSc MA2*, Samiya Mahmood3*, Soubera Rymell2*, Michael Smith3*, Antonella Sultana3*, Nicole Eichert, PhD2*, Michele Pansini, MD2*, Helena Thomaides-Brears, PhD2*, Bethan Psaila, MD, PhD1 and Adam J Mead, MD PhD1

1Medical Research Council Weatherall Institute of Molecular Medicine and NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
2Perspectum Ltd, Oxford, United Kingdom
3Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Ming-Chung Kuo, M.D.1*, Chien-Chin Lin, MD, PhD2*, Hsuan-Yu Lin, M.D.3*, Jyh-Pyng Gau, MD4*, Ming-Chung Wang, MD5*, Ming-Chih Chang, M.D.6*, Tsung-Chih Chen7*, Shih-Peng Yeh, MD8*, Yeu-Chin Chen Sr., MD9, Cih-En Huang, MD10*, I-Ju Chiang, MA11*, Chu-Han Chung12*, Yee-Ming Lee, PhD13, Fan-Chen Ku, M.D.13* and Cheng-Shyong Chang, MD14*

1Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan
2Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan
3Changhua Christian Hospital, Changhua, Taiwan
4Taipei Veterans General Hospital, Taipei, Taiwan
5Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
6Mackay Memorial Hospital, Taipei, Taiwan
7Taichung Veterans General Hospital, Taichung, TWN
8Medical University Hospital, Taichung, Taiwan
9Division of Hematology/Oncology, Department of Internal Medicine, Tri-Service General Hospital (TSGH), Taipei, Taipei (City), Taiwan
10Division of Hematology and Oncology, Department of Medicine, Chang Gung Memorial Hospital at Chiayi, Chiayi, Taiwan
11Novartis (Taiwan) Co. Ltd, Taipei, TWN
12Novartis (Taiwan) Co. Ltd, Taipei, Taiwan
13Novartis (Taiwan) Co. Ltd., Taipei, Taiwan
14Changhua Christian Hospital, Changhua City, Taiwan

Fabrizio Cavalca1,2*, Francesca Palandri, PhD, MD3,4*, Novella Pugliese, MD5*, Alessia Ripamonti, MD1,6*, Ambra Di Veroli, MD7*, Mattia Biondo, MD8,9*, Carlo Gambacorti-Passerini, MD10,11, Roberto Latagliata, MD12* and Elena Maria Elli, MD13*

1Università degli Studi di Milano-Bicocca, Milano, Italy
2Hematology Division and Bone Marrow Transplant Unit, San Gerardo Hospital, ASST Monza, Monza, Italy
3IRCCS Azienda Ospedaliero-Universitaria S. Orsola-Malpighi, Bologna, Istituto di Ematologia "Seràgnoli, Bologna, Italy
4Department of Hematology/Oncology, Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
5Hematology - Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy
6Hematology Division and Bone Marrow Unit, San Gerardo Hospital, ASST Monza, Monza, Italy., Monza, Italy
7Hematology, Belcolle Hospital, Viterbo, Italy
8IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
9Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
10Dept of Medicine and Surgery, University of Milano Bicocca, Monza, MB, Italy
11University of Milano-Bicocca, Milan, Italy
12Haematology Division, Ospedale Belcolle, Viterbo, Italy, Viterbo, ITA
13Hematology Division, Ospedale San Gerardo - ASST Monza, Monza, Italy

Raphael Costa Bandeira de Melo, MD1*, Tania Rubia Rocha2*, Alexandre Eiji Kayano1*, Guilherme Souza Villar Cassimiro Fonseca2*, Vanderson Rocha, Prof, MD, PhD1,2*, Wellington F Silva Jr., MD PhD1 and Fernanda S Seguro, MD1,2*

1Instituto do Cancer do Estado de Sao Paulo da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil
2Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil

Giuseppe Gaetano Loscocco, MD1*, Raffaella Santi, MD2*, Carmela Mannarelli, PhD1*, Francesco Mannelli, MD1*, Francesca Gesullo, BSci1*, Giacomo Coltro, MD1*, Paola Guglielmelli, MD, PhD1, Umberto Gianelli, MD3* and Alessandro Maria Vannucchi, MD4

1CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
2Hemopathology Unit, AOU Careggi, University of Florence, Florence, Italy
3Pathology Unit, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy
4University of Florence, Firenze, Italy

Kristen M. Pettit1, Harinder Gill, MD, MBBS, FRCP, FRCPath2, Abdulraheem Yacoub, MD3, Terrence Bradley, MD4, Aaron T. Gerds, MD, MS5, Maciej Tatarczuch, BMBS6, Jake Shortt, FRACP, FRCPA, PhD7, Natasha Joan Curtin, MD, FRACP, FRCPA8*, James M. Rossetti, DO9, Kate Burbury, MBBS, FRACP, FRCPA, DPhil10*, Adam J Mead, MD PhD11, Joachim R Göthert, MD12, Steffen Koschmieder13, Matt Reyer, PhD14*, Benjamin Siranosian, PhD14*, Georges Natsoulis, Ph.D.14*, William S Stevenson, MBBS, PhD, FRACP, FRCPA15, Joanne Ewing, MD, PhD16*, Joseph M. Chacko, MD, MBBS, BSc, FRCP, FRCPath17, Elisa Rumi18*, Anna B. Halpern, MD19, Francesca Palandri, PhD, MD20*, Nicola Vianelli, MD21*, Francesco Passamonti, MD22*, Ruben Mesa, MD, FACP23, Monia Marchetti24*, Claire N. Harrison, DM25, Alessandro M. Vannucchi26, Justin Watts, MD27, David M Ross, MBBS, PhD, FRACP, FRCPA28*, Moshe Talpaz, MD29 and Hugh Young Rienhoff Jr., MD14

1Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
2Department of Medicine, The University of Hong Kong, Hong Kong, Hong Kong
3The University of Kansas Cancer Center, Leawood, KS
4University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
5Department of Hematology and Medical Oncology,, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
6Monash Health, Melbourne, Australia
7School of Clinical Sciences at Monash Health, Peter MacCallum Cancer Centre, Clayton, VIC, Australia
8Monash Health, Monash University, Melbourne, Australia
9UPMC Hillman Cancer Center, Pittsburgh, PA
10Peter MacCallum Cancer Centre, Melbourne, Australia
11Medical Research Council Weatherall Institute of Molecular Medicine and NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
12Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
13Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, University Hospital of Aachen, Aachen, Germany
14Imago BioSciences, San Carlos, CA
15Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia
16University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
17The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, United Kingdom
18Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
19Department of Medicine, University of Washington, Seattle, WA
20IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy
21Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology L. e A. Seragnoli, Hematology, Bologna, Italy
22Hematology, Università Degli Studi Dell'Insubria, Varese, VA, Italy
23Mays Cancer Center at UT Health San Antonio, San Antonio, TX
24Hematology Unit & TMO Center, AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
25Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom
26CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, Firenze, Italy
27Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, FL
28Department of Haematology, Flinders Medical Centre and University, Adelaide, SA, Australia
29University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

Alexandros Rampotas, MRCP, PGDip1*, Luke Carter-Brzezinski, MBChB2*, Tim C.P Somervaille, PhD FRCP FRCPath2, James Forryan1*, Bethan Psaila, MD, PhD3, Adam J Mead, MD PhD3, Mamta Garg, MD, FRCP, FRCPath4*, Heather Laing4*, Louise Wallis5*, Nauman M Butt, MBChB, MRCP(UK), FRCPath, MD6*, Conal McConville7*, Ali Sahra8*, Andrew McGregor9*, Hannah Cowan10*, Andrew J. Innes, PhD, FRCPath, MRCP11*, Joanne Ewing12*, Matthew Carter13*, Peter Dyer14*, Chun Huat Teh15*, Sebastian Francis, MBChB, FRCPath, MD16*, Frances Wadelin, MB ChB, PhD, FRCPath17*, Claire N. Harrison, DM10, Anna L Godfrey, BMBCh, PhD13*, Elizabeth Kulakov18*, Donal P. McLornan, MD, PhD1,19* and Jonathan Lambert, BmedSci, PhD, FRCP, FRCPath1*

1Haematology Department, University College London Hospitals NHS Foundation Trust, London, United Kingdom
2Haematology Department, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
3Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
4Haematology Department, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
5Haematology Department, University Hospitals Dorset NHS Foundation Trust, Bournemouth, United Kingdom
6The Clatterbridge Cancer Centre, Bebington, United Kingdom
7Haematology Department, Belfast Health & Social Care Trust, Belfast, United Kingdom
8Haematology Department, King's College Hospital NHS Foundation Trust, London, United Kingdom
9Haematology Department, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom
10Haematology Department, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
11Haematology Department, Imperial College Healthcare NHS Trust, London, United Kingdom
12Haematology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
13Haematology Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
14Haematology Department, University hospitals of North Midlands, Stoke, United Kingdom
15Haematology Department, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
16Haematology Department, Sheffield Teaching Hospitals NHS trust, Sheffield, United Kingdom
17Haematology Department, Nottingham University Hospital, Nottingham, United Kingdom
18Dermatology Department, University College London Hospitals, London, United Kingdom
19Haematology Department, Guy's and St Thomas' NHS Trust, London, United Kingdom

James T. England, MD1, Eshetu G. Atenafu, M.Sc., P.Stat2*, James A. Kennedy, MD, PhD3, Burhan Goraya1*, Verna Cheung, RN BScN MN1*, Taylor Nye, RN MN1*, Karine Gauthier, MD1, Marta B. Davidson, MD, PhD4, Aniket Bankar, MBBS, MD, DM4, Hassan Sibai, MBBS, MD1*, Dawn Maze, MD, FRCPC, MSc4, Auro Viswabandya5 and Vikas Gupta, MD, FRCP, FRCPath1

1Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
3Sunnybrook Health Sciences Centre, Toronto, ON, Canada
4Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
5Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Francesca Palandri, PhD, MD1*, Elena Maria Elli, MD2*, Alessandra Iurlo, MD, PhD3*, Giuseppe Auteri, MD4,5*, Malgorzata Monika Trawinska, MD6*, Massimiliano Bonifacio, MD7*, Francesco Mendicino8*, Roberto Latagliata, MD9*, Camilla Mazzoni, MD4,5*, Mattia Biondo, MD4,5*, Valentina Sangiorgio, MD2*, Daniele Cattaneo, MD3*, Edoardo Tamellini, MD7*, Elisabetta Abruzzese, MD10, Mauro Krampera, MD, PhD7*, Stefana Impera, MD11*, Bruno Garibaldi, MD12*, Simona Paglia, PhD5*, Daniela Bartoletti, MSc5*, Nicola Vianelli, MD5*, Michele Cavo, MD4,5*, Florian H. Heidel, MD13, Massimo Breccia14*, Giovanni Caocci, MD15 and Giuseppe A. Palumbo12*

1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy
2Hematology Division, Ospedale San Gerardo - ASST Monza, Monza, Italy
3Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
4Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
5IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
6Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy
7Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
8Hematology Unit, Department of Hemato-Oncology, Ospedale Annunziata, Cosenza, Italy
9Haematology Division, Ospedale Belcolle, Viterbo, Italy, Viterbo, ITA
10Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Roma, I, Italy
11Division of Hematology, ARNAS Garibaldi-Nesina, Catania, Italy
12Dipartimento di Scienze Mediche Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", Unità Operativa di Ematologia con TMO AOU "Policlinico - San Marco", Università degli Studi di Catania, Catania, Italy
13Innere Medicin C, Universitätsmedizin Greifswald, Greifswald, Germany
14A.O.U. Policlinico Umberto I, Università degli Studi di Roma "La Sapienza", Rome, Italy
15Hematology Unit, Businco Hospital, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy

Orly Leiva, MD1, Emaad Siddiqui, MD2*, Gabriela S. Hobbs, MD3 and Sripal Bangalore, MD1*

1Division of Cardiovascular Medicine, Department of Medicine, New York University Grossman School of Medicine, New York City, NY
2New York University Grossman School of Medicine, New York City, NY
3Cancer Center, Massachusetts General Hospital, Boston, MA

Yuhui Zhang1*, Yingdi Han1*, Guangshuai Teng1*, Chenxiao Du1*, Shan Gao2*, Weiping Yuan, PhD, MD3, Lei Zhang, MD, PhD4* and Jie Bai, MD1

1Department of Hematology, The Second Hospital of Tianjin Medical University, Tianjin, China
2Second Hospital of Tianjin Medical University, tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China

Aldo A. Acosta Medina, MD1, Saurabh Zanwar2, Gordon Ruan, MD2*, Jithma P. Abeykoon, MD2, Karen Rech, MD3*, Aishwarya Ravindran, MBBS4, N. Nora Nora Bennani, MD2, Caroline J Davidge-Pitts, MBBCh5*, Matthew Koster, MD6*, Jay Ryu, MD7*, Mithun V. Shah, MD, PhD2, W. Oliver Tobin, MB BCh8*, Robert Vassallo, MD7*, Jason R. Young, MD9*, Gaurav Goyal, MD10,11 and Ronald Go, MD2

1Department of Internal Medicine, Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
4Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL
5Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, MN
6Division of Rheumatology, Mayo Clinic, Rochester, MN
7Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN
8Department of Neurology, Mayo Clinic, Rochester, MN
9Department of Radiology, Mayo Clinic, Jacksonville, FL
10Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
11Research Collaborator (limited-tenure), Division of Hematology, Mayo Clinic, Birmingham, AL

Maymona Abdelmagid1*, Aref Al-Kali, MD2, Kebede H. Begna, MD3, William J. Hogan, MB, BCh2, Mark R. Litzow, MD2, Abhishek A. Mangaonkar, MBBS2, Mrinal M. M. Patnaik, MD, MBBS2, Michelle A Elliott, MD2, Hassan B. Alkhateeb, MD2*, Min Shi, MD, PhD4, Matthew Howard, MD5*, Kaaren K. Reichard, MD4*, Rhett P. Ketterling, MD4*, Animesh Pardanani, MBBS, PhD 2, Naseema Gangat, MBBS2 and Ayalew Tefferi, MD2

1Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Divison of Hematology, Mayo Clinic, Rochester, MN
4Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
5Mayo Clinic, Rochester

Barbara Mora, MD1,2*, Giacomo Pellegrini, MSc1*, Matteo Franchi, PhD3,4*, Margherita Maffioli, MD1*, Marco Brociner, MD1*, Paola Guglielmelli, MD, PhD5, Maria Teresa Voso, MD6, Tiziana Ottone, PhD6*, Marta Ubezio, MD7*, Giulia Maggioni, MD7*, Michele Merli, MD1*, Alessandro M. Vannucchi5, Matteo G. Della Porta, MD7,8*, Giovanni Corrao, PhD3,4* and Francesco Passamonti, MD1,2*

1Hematology, Ospedale di Circolo e Fondazione Macchi, ASST Sette Laghi, Varese, Italy
2Department of Medicine and Surgery, University of Insubria, Varese, Italy
3National Center for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy
4Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy
5CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
6Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
7Cancer Center, IRCCS Humanitas Research Hospital & Humanitas University, Rozzano, Italy
8Department of Biomedical Sciences, Humanitas University, Milan, Italy

*signifies non-member of ASH